Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01529385
Other study ID # ORT 112
Secondary ID
Status Completed
Phase N/A
First received February 3, 2012
Last updated November 7, 2014
Start date February 2012
Est. completion date September 2014

Study information

Verified date November 2014
Source Rosalind Franklin University of Medicine and Science
Contact n/a
Is FDA regulated No
Health authority United States: Rosalind Franklin University Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether a specially designed sock for people with diabetes and swelling in the legs can reduce the swelling, improve blood flow to the legs, and improve physical activity patterns of those individuals by providing mild compression to their legs.


Description:

Peripheral arterial disease (PAD) is commonly associated with diabetes. Clinicians are often reluctant to apply compressive stockings to patients with diabetes and swollen legs due to fear of exacerbating the symptoms of PAD. The study sock is a newly formulated sock that offers mild compression (18-25mmHg). The sock is made especially for the diabetic patient who suffers from concomitant lower extremity edema.

Eighty patients with diabetes and lower extremity edema will be recruited. Upon ensuring enrollment criteria are met, baseline edema (as measured by circumference of foot, ankle and calf), ankle brachial index (ABI), skin perfusion pressure, and cutaneous fluid level (as measured by MoistureMeter) will be assessed. Subjects will then be provided four pairs of socks. Subjects will be randomized in a 1:1 distribution to receive either the mild compression diabetic socks or a standard diabetic sock. They will return for four weekly follow up visits.

Additionally a sub-set of 30 subjects will be monitored for changes in physical activity pre and post sock usage. Physical activity monitors will be used to assess daily physical activity for 48hrs prior to receiving the socks and after wearing the socks for four weeks an additional 48hrs will be monitored.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Male or female with lower extremity edema aged 18 or older with the ability and willingness to provide Informed consent

- Patient's ankle-brachial systolic pressure index > 0.6 and toe-brachial index > 0.3

- Patient is willing to participate in all procedures and follow up evaluations necessary to complete the study.

- Patient has diabetes type 1 or type 2 confirmed by patient's primary care physician.

Exclusion Criteria:

- Patients with active wound infection, or untreated osteomyelitis, gangrene

- Patients with dementia, or impaired cognitive function that would prohibit study compliance

- Patients with wide spread malignancy or systemically immuno-compromising disease

- Patients who are unable or unwilling to participate in all procedures and follow up evaluations

- Patient with deep and/or large ulcers that require copious bandaging and may affect efficacy of socks. Patients with superficial ulcers that only require a light dressing are not excluded. The ulcer, if present, must be superficial and cannot exhibit any clinical signs of infection

- Patients with restless leg syndrome, Parkinson's disease, or other disease that will cause involuntary movement during microvascular assessment

- Patients with severe edema or calf circumference greater than 24" or 46cm

- Patients with severe lymphedema

- Patients with edema that in the opinion of the investigator requires higher compression than the 18-25mmHg provided by the compression socks

- Patients who are currently wearing compression hose. (Patients who have been prescribed compression hose but have not worn compression stockings for the past 6 months can be included in the study)

- Patients unable to walk one hundred feet.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Edema
  • Mild to Moderate Edema of Diabetic Legs

Intervention

Device:
mild compression diabetic sock
A diabetic sock that provides mild compression (18-25mm Hg) is to be worn everyday for four weeks
Standard diabetic sock
A diabetic sock that is not designed to provide compression is to be worn everyday for four weeks

Locations

Country Name City State
United States Rosalind Franklin University Health System North Chicago Illinois

Sponsors (2)

Lead Sponsor Collaborator
Rosalind Franklin University of Medicine and Science Madigan Army Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary lower extremity edema The circumference of the foot, ankle and calf will be measured by a tape measurer. Cutaneous fluid will be measured non-invasively by a MoistureMeter. change from baseline after 1, 2, 3, and 4 weeks of sock usage No
Primary lower extremity vascular status The ankle-brachial index, toe-brachial index, skin perfusion pressure and pulse volume recordings will be measured. change from baseline after 1,2,3, and 4 weeks of sock usage Yes
Secondary physical activity level Physical activity monitors will be used to assess physical activity patters of participants for 48 hours prior to initiating sock usage and for 48 hours after the participants have worn the socks for four weeks. baseline and after four weeks of wearing the socks No